Bloomberg: Syngenta Rejects Recent Takeover Offer.

Nov 13, 2015

Farms.com Editors

As reported by Bloombery, Syngenta has reportedly rejected another takeover offer, this one from a Chinese Company.

Syngenta rejected a $42 billion takeover offer by state-owned China National Chemical Corp. Recently, the Swiss-based company turned down a $46 billion dollar offer from Monsanto saying the price was too low.

In a Bloomberg story, it is reported that talks with ChemChina are expected to continue, but no guarantee that a deal will be reached. Bloomberg also adds that Syngenta is considering other buyers, as well as looking at companies they may be interested in acquiring.

This continues a series of company strategic discussions.

Here is a link to the Bloomberg news story.

http://www.bloomberg.com/news/articles/2015-11-12/chemchina-is-said-to-be-in-talks-to-acquire-syngenta

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.